Altered microtubule dynamics in Mecp2‐deficient astrocytes
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Rett syndrome (RTT) is a severe neurodevelopmental disorder caused by mutations in the gene MECP2 encoding the methyl‐CpG binding protein 2. This genetic disease affects predominantly girls and is characterized by a period of normal development that lasts for 8–18 months, followed by neurologic regression affecting both motor and mental abilities. Previous studies performed on brains from RTT subjects and Mecp2‐deficient mice showed striking changes in neuronal maturation and dendritic arborization. Recently, we showed that expression of stathmin‐like 2 (STMN2) was significantly reduced in fibroblasts from RTT patients, and similar results were obtained in the cerebellum of Mecp2‐deficient mice. Because assembly and dynamics of microtubules are known to be modulated by STMN2, we studied microtubule dynamics in brain cells from Mecp2‐deficient mice. We observed that Mecp2 deficiency affects microtubule dynamics in astrocytes from Mecp2‐deficient mice. Our data reinforce the fact that the loss of Mecp2 in astrocytes may influence the onset and progression of RTT. These results imply that Mecp2 has a stabilizing role in microtubule dynamics and that Mecp2 deficiency, which is associated with STMN2 down‐regulation, could lead to impaired microtubule stability, hence explaining the dendritic abnormalities observed in RTT brains. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
A role for glia in the progression of Rett’s syndrome
Lioy, D. T., Garg, S. K., Monaghan, C. E., Raber, J., Foust, K. D., Kaspar, B. K., Hirrlinger, P. G., Kirchhoff, F., Bissonnette, J. M., Ballas, N., et al. (2011) · Nature · doi:10.1038/nature10214 · Cited by 496 · cited 3×
“Although we are not aware of any study addressing which type of cells causes disease progression, re-expression of Mecp2 preferentially in astrocytes significantly improved locomotion and anxiety levels, restored respiratory abnormalities to a normal pattern, and greatly prolonged life span compared with globally null…”
BackgroundResultInfluentialNon–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology
Ballas, N., Lioy, D. T., Grunseich, C., & Mandel, G. (2009) · Nature Neuroscience · doi:10.1038/nn.2275 · Cited by 466
Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized
Bienvenu, T., & Chelly, J. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1878 · Cited by 289
Self-citationBelichenko, P. V., Wright, E. E., Belichenko, N. P., Masliah, E., Li, H. H., Mobley, W. C., & Francke, U. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.22009 · Cited by 272
Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus
Ben-Shachar, S., Chahrour, M., Thaller, C., Shaw, C. A., & Zoghbi, H. Y. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp181 · Cited by 253
Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K., & Goto, Y.-I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.537 · Cited by 221
Garcia, O., Torres, M., Helguera, P., Coskun, P., & Busciglio, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014200 · Cited by 122 · cited 1×
“Garcia et al. (2010) recently identified astrocyte dysfunction as a significant factor in spine and synaptic pathology in the Down syndrome brain and provided a mechanistic explanation through the down-regulation of thrombospondine-1 (TSP-1) expression in mutant astrocytes.”
Background
Cited by
An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy
Millan, M. J. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.015 · Cited by 229
Pacheco, N. L., Heaven, M. R., Holt, L. M., Crossman, D. K., Boggio, K. J., Shaffer, S. A., Flint, D. L., & Olsen, M. L. (2017) · Molecular Autism · doi:10.1186/s13229-017-0174-4 · Cited by 90
“Previous work has implicated aberrant astrocyte microtubule dynamics [139, 140] and decreased astrocyte morphological complexity [72] in RTT.”
BackgroundRedox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome
Signorini, C., Leoncini, S., De Felice, C., Pecorelli, A., Meloni, I., Ariani, F., Mari, F., Amabile, S., Paccagnini, E., Gentile, M., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/195935 · Cited by 61
“Fibroblasts have been used in the RTT scientific research to evaluate gene mutation and epigenetic process [37], differentiation to induced pluripotent stem (iPS) [38], cellular response subsequent to MECP2 mutation [39], reduction of stathmin-like 2 [40], and the effects of NB54 and other rationally designed aminogly…”
MethodAlbizzati, E., Florio, E., Miramondi, F., Sormonta, I., Landsberger, N., & Frasca, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.823060 · Cited by 12
Metadata
- Authors
- Nectoux, J., Florian, C., Delepine, C., Bahi‐Buisson, N., Khelfaoui, M., Reibel, S., Chelly, J., & Bienvenu, T.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2012-01-18
- Volume
- 90
- Issue
- 5
- Pages
- 990-998
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1971735392
- Cited by
- 29
- References
- 9
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altered microtubule dynamics in Mecp2‐deficient astrocytes. https://app.cochat.ai/papers/10.1002/jnr.23001
- The paper
- Nectoux, J., Florian, C., Delepine, C., Bahi‐Buisson, N., Khelfaoui, M., Reibel, S., Chelly, J., & Bienvenu, T. (2012). Altered microtubule dynamics in Mecp2‐deficient astrocytes. Journal of Neuroscience Research. https://doi.org/10.1002/jnr.23001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.